Baruch Future Ventures
Thomas Baruch joined the Calysta Board of Directors in 2013 and was named Executive Chairman of the Board in 2014. He retired in 2014 from Formation 8, where he was a founding member and chairman. Mr. Baruch formed CMEA Capital in 1988 with New Enterprise Associates (NEA). He was responsible for managing a total of $1.2 billion of capital across seven funds from inception to July of 2010. While at CMEA, Mr. Baruch also led investments including major IPO’s and significant liquidity events for Aclara Biosciences, Codexis, Inc., Entropic Communications, Flextronics, Inc., Intermolecular, Silicon Spice and Symyx Technologies. He is now Partner Emeritus of CMEA. Earlier in his career, Mr. Baruch worked at Exxon Mobil for 12 years. When he left in 1982, he was serving as President of the Exxon Materials Division. Next, he founded Microwave Technology, Inc., a manufacturer and seller of gallium arsenide (GaAs) integrated circuits for defense applications. Mr. Baruch served as CEO for 6 years prior to founding CMEA Capital.
Currently, Mr. Baruch serves as Chairman of the Board of Codexis, Inc. (NASDAQ: CDXS) and Intermolecular, Inc. (NASDAQ: IMI). Mr. Baruch also currently serves on the boards of CNano Technologies, Exela Pharm Sci, Foro Energy and Wildcat Discovery Technologies.
Mr. Baruch is a member of the National Advisory Council on Innovation and Entrepreneurship (NACIE), where he advises the U.S. Department of Commerce and the White House. Mr. Baruch is a member of the Executive Committee of the U.S. Council of Competitiveness and a member of the Steering Committee of its ESIS (Energy, Security, Innovation and Sustainability) Initiative and the U.S. Manufacturing Competitiveness Initiative. Mr. Baruch is also a member of the “Brain Trust” of the ARPA-E program within the U.S. Department of Energy. Mr. Baruch recently served as a member of the IPO Task Force advising the U.S. Department of the Treasury in connection with necessity of programs to stimulate startup activity in the U.S. Mr. Baruch is also a member of the board of directors of the Society of Kauffman Fellows, a member of the Climate Recovery Cabinet of the Sierra Club, and a trustee of the “That Man May See” program within the University of California San Francisco. Mr. Baruch is an advisor to Hasso Plattner Ventures, a leading German venture capital fund. He has recently joined the Board of CASE, Rensselaer Polytechnic Institute’s Center for Architecture Science and Ecology.
In addition, Mr. Baruch is a Trustee of the Rensselaer Polytechnic Institute where he was Co-Chairman of its recent $1.1 billion Capital Campaign. He and his wife, Johanna, are Founders of the Baruch Center for Solar Biochemical Energy Research at the School of Science of Rensselaer Polytechnic Institute and the Richard Baruch, M.D. Endowed Chair in metabolic pathways of the School of Biotechnology and Interdisciplinary Studies.
Mr. Baruch holds an engineering degree from Rensselaer Polytechnic Institute and a Juris Doctor degree from Capital University. He is a member of the State Bar of Ohio and is a registered patent attorney.
Craig Barratt, Ph.D.
Craig Barratt, Ph.D., a leading consumer electronics entrepreneur, joined the Calysta Board of Directors in 2013. He is Senior Vice President, Access and Energy, at Google. Prior to joining Google, he was the president of Qualcomm Atheros, the network and connectivity subsidiary of Qualcomm (NASDAQ:QCOM).
Dr. Barratt joined Qualcomm in 2011 following its acquisition of Atheros Communications, a fabless semiconductor company. From 2003, he was president, CEO and a director of Atheros. He led the company through its 2004 IPO and growth to over $900 million in revenue in 2010.
Dr. Barratt previously served as Atheros’ vice president of technology from 2002 until 2003. Prior to joining Atheros, he held the role of executive vice president and general manager of ArrayComm, a company specializing in multi-antenna signal processing. He also serves on the Board of Directors at Intuitive Surgical (NASDAQ: ISRG), a pioneer in robotic assisted surgery.
Dr. Barratt holds Ph.D. and Master of Science degrees in electrical engineering from Stanford University, as well as a Bachelor of Engineering degree in electrical engineering and a Bachelor of Science degree from the University of Sydney in Australia. Dr. Barratt has been granted over 30 patents in a variety of wireless and related technologies and has co-authored a book on linear controller design, various technical publications and open source software.
Walden Riverwood Ventures
Nicholas Brathwaite joined the Calysta Board of Directors in 2015. He is a founding partner of Riverwood Capital. Nicholas has spent over 25 years developing and evaluating technology. From 1996 to 2007, he Served as the Chief Technology Officer at Flextronics, where he worked alongside Michael Marks, former CEO. At Flextronics, Nicholas was innovative in his drive to move the company into product development, and he oversaw the launch and growth of several of Flextronics’ largest business units.
Previously, he was a founding member of nChip responsible for development of the industry-leading advanced multi-chip module assembly process. More recently with Riverwood, Nicholas served as the interim CEO for Aptina Imaging from February 2007 to August 2008. His unique combination of technology know-how and commercial judgment will add value throughout the investment life-cycle at Riverwood. Nicholas earned an M.Sc. Degree in Polymer Science Engineering from the University of Waterloo, Canada and a B.Sc.(Honors) Degree in Applied Chemistry from McMaster University, Canada. He is a director of Globant, Arkmicro, Power Integrations, Tessera Technologies, Inc. and Chairman of the Board of Aptina Imaging.
Torkell Gjerstad joined the Calysta Board of Directors in 2014. He is President and General Manager, IRIS-Forskningsinvest AS, the investment unit of IRIS (International Research Institute of Stavanger), Stavanger, Norway. Mr. Gjerstad has more than 35 years experience within research institutions and exploration, production and technology companies. He has managed a high growth international company with more than 500 staff and has a broad understanding of technology, business and risk management. He has managed more than 20 M&A processes.
After a short period as manager of Technica’s Norwegian subsidiary, he became Managing Director for the Technica Group, with operations in Norway, USA, Belgium, Australia and Malaysia. Following DNV’s acquisition of Technica, he became Vice President of DNV Industry, managing DNV Industry UK Ltd. He went on to develop Smedvig Technologies into Roxar, an internationally recognized provider of reservoir software and monitoring systems. Revenues grew from NOK 85m to 440m in only five years, including high organic growth. Roxar was at the time listed on the Oslo Stock Exchange.
At Acona, Mr. Torkell rescued the company from bankruptcy in 2002 and subsequently built a successful consulting business, with revenues growing from NOK 30m to well over 300m in six years. During these years, the company expanded its services into drilling management and established Norway’s first commercial emergency control centre. He initiated the merger between Acona Wellpro to form Norway’s leading drilling management company, with revenues exceeding NOK 650m. Mr. Torkell holds a MSc. Degree in applied physics and operations research from the Norwegian Institute of Technology.
Purnesh Seegopaul, Ph.D.
Purnesh Seegopaul, Ph.D., joined the Calysta Board of Directors in 2013. He is a General Partner at Pangaea Ventures; a venture capital firm focused on building early stage companies leveraging advanced materials innovations to solve major problems in large markets. Currently, he serves as Chairman of the Board at CNano Technologies and Envia Systems. He was recently on the Board at Cyrium Technologies and Semprus BioSciences, acquired by Teleflex in 2012.
Dr. Seegopaul led advanced materials startups and held executive leadership positions in advanced materials companies working in the energy, electronics, tooling and environmental markets. In addition to pioneering work on nanostructured materials commercialization, his technology development activities included inorganic catalysts and enzymes, thin films and electronic materials, battery and fuel cell materials, and robust production technologies. He holds nine US patents and was appointed to the advisory board of the Marcel-Dekker Encyclopedia of Nanoscience and Nanotechnology.
Dr. Seegopaul received his B.Sc. from the University of Guyana, Ph.D. in Chemistry from the University of New South Wales in Sydney, Australia where he was a UNESCO Scholar and completed his post-doctoral fellowship at the University of Delaware.
Alan Shaw, Ph.D., President and Chief Executive Officer
Alan Shaw, Ph.D., is President and Chief Executive Officer of Calysta, and a member of the Board of Directors. He joined in 2012. Dr. Shaw is a veteran biotechnology entrepreneur and chemical industry executive, with more than 25 years experience building and leading technology companies.
Before joining Calysta, he served for ten years as President & CEO and a director of Codexis, a developer of cost-advantaged processes for production of biofuels, biobased chemicals and pharmaceuticals. During his tenure, Codexis completed an IPO and expanded from a startup to a global industrial biotechnology company with operations in the United States, Europe and Asia.
In 2010, Dr. Shaw received the Ernst and Young Entrepreneur® of the Year Award in the life sciences category for Northern California. He serves as a biotechnology advisor to the governments of the United Kingdom and Malaysia, and is a frequent speaker on energy to leading business and industry conferences.
Prior to Codexis, Dr. Shaw held senior operating and business development positions in the United Kingdom for Chiroscience Group plc and for the chemical and biopharmaceutical units of Clariant and BTP plc from 1994-99. For the previous 15 years, he held management and scientific leadership positions for Imperial Chemical Industries plc (ICI)/Zeneca, including Business Head, Fine Chemicals and Marketing Manager, European Sales. Dr. Shaw is a past board member of BIO and chair of BIO’s industrial and environmental section. He holds a bachelor’s degree in chemistry from Teesside University and a Ph.D. in chemistry from the University of Durham, England, and is a fellow of the Royal Society of Chemistry.
Mike Velings joined the Calysta Board of Directors in 2015. He is the founder and the driving force behind Aqua-Spark, a global investment fund for sustainable aquaculture, combining a healthy financial profit with environmental and social impact. A lifelong entrepreneur, Mike has spent decades jumpstarting a range of successful businesses. Among other ventures, he co-founded Connexie, which has helped catalyze a professional employment industry across the Netherlands. Mike naturally combines his business background with environmental and social engagement. He understands the potential for business to create durable solutions to complex world problems. With this in mind, Mike founded A-Spark: an investment company that assists entrepreneurs across the globe in realizing their visions of a start-up with a world-changing element. Through A-Spark he has invested in a broad range of ventures over the years– both in the developed and developing world. Mike serves on several boards and is also a member of the Chairman’s Council of Conservation International and an Honorary Global Marine Fellow.